Table 4. How patients usually refer to inhalers when talking with a healthcare professional.
Patient group | Usually, n (%) | Often, n (%) | Sometimes, n (%) | Never, n (%) | Total, n | P value |
---|---|---|---|---|---|---|
By colour (e.g., ‘I use my blue inhaler if my symptoms get worse’) | ||||||
Asthma (n=1,755) | 813 (50.7%) | 286 (17.8%) | 332 (20.7%) | 172 (10.7%) | 1,603 | 0.86 |
COPD (n=212) | 79 (48.2%) | 32 (19.5%) | 33 (20.1%) | 20 (12.2%) | 164 | |
All (n=2,127) | 943 (49.8%) | 309 (17.9%) | 397 (21.0%) | 214 (11.3%) | 1893 | |
By the brand name (e.g., Ventolin, Flixotide, Symbicort) | ||||||
Asthma (n=1,755) | 513 (35.1%) | 313 (19.6%) | 458 (28.7%) | 313 (19.6%) | 1,597 | <0.005 |
COPD (n=212) | 80 (48.8%) | 24 (14.6%) | 40 (24.4%) | 20 (12.2%) | 164 | |
All (n=2,127) | 673 (35.4%) | 360 (18.9%) | 523 (27.5%) | 346 (18.2%) | 1902 | |
By the medicine inside (generic name) (e.g., salbutamol, salmeterol, budesonide) | ||||||
Asthma (n=1,755) | 250 (16.7%) | 205 (13.7%) | 591 (39.4%) | 454 (30.3%) | 1,500 | <0.005 |
COPD (n=212) | 45 (34.1%) | 17 (12.9%) | 45 (34.1) | 25 (18.9%) | 132 | |
All (n=2,127) | 328 (18.7%) | 247 (14.1%) | 679 (38.7%) | 502 (28.6%) | 1757 |